脱氢雌马酚结构式
|
常用名 | 脱氢雌马酚 | 英文名 | Phenoxodiol |
|---|---|---|---|---|
| CAS号 | 81267-65-4 | 分子量 | 240.254 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 463.7±45.0 °C at 760 mmHg | |
| 分子式 | C15H12O3 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 234.3±28.7 °C | |
| 符号 |
GHS07, GHS09 |
信号词 | Warning |
脱氢雌马酚用途Phenoxodiol是一种合成genestein的类似物,激活线粒体caspase系统,抑制XIAP(一个凋亡抑制剂),使癌细胞对fas介导的凋亡敏感。Phenoxodiol还通过稳定可分裂复合物抑制DNA拓扑异构酶II,从而阻止DNA复制。Phenoxodiol 在细胞周期的G1/S期诱导细胞周期阻滞,通过独立于p53的方式上调p21WAF1。 |
| 中文名 | 脑益嗪 |
|---|---|
| 英文名 | 3-(4-hydroxyphenyl)-2H-chromen-7-ol |
| 中文别名 | 3-(4-羟基苯基)-2H-1-苯并吡喃-7-醇 | 脱氢雌马酚 |
| 英文别名 | 更多 |
| 描述 | Phenoxodiol是一种合成genestein的类似物,激活线粒体caspase系统,抑制XIAP(一个凋亡抑制剂),使癌细胞对fas介导的凋亡敏感。Phenoxodiol还通过稳定可分裂复合物抑制DNA拓扑异构酶II,从而阻止DNA复制。Phenoxodiol 在细胞周期的G1/S期诱导细胞周期阻滞,通过独立于p53的方式上调p21WAF1。 |
|---|---|
| 相关类别 | |
| 靶点 |
Caspase, DNA topoisomerase II[1][2]. |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 463.7±45.0 °C at 760 mmHg |
| 分子式 | C15H12O3 |
| 分子量 | 240.254 |
| 闪点 | 234.3±28.7 °C |
| 精确质量 | 240.078644 |
| PSA | 49.69000 |
| LogP | 4.35 |
| InChIKey | ZZUBHVMHNVYXRR-UHFFFAOYSA-N |
| SMILES | Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1 |
| 蒸汽压 | 0.0±1.2 mmHg at 25°C |
| 折射率 | 1.679 |
| 储存条件 | 2-8°C,干燥,密封 |
| 符号 |
GHS07, GHS09 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H400 |
| 警示性声明 | P273 |
| 危害码 (欧洲) | Xi |
| 危险品运输编码 | UN 3077 9 / PGIII |
| 海关编码 | 2932999099 |
| 脱氢雌马酚上游产品 10 | |
|---|---|
| 脱氢雌马酚下游产品 1 | |
| 海关编码 | 2932999099 |
|---|---|
| 中文概述 | 2932999099. 其他仅含氧杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Involvement of a Hydrophobic Pocket and Helix 11 in Determining the Modes of Action of Prenylated Flavonoids and Isoflavonoids in the Human Estrogen Receptor.
ChemBioChem. 16 , 2668-77, (2016) Six prenylated (iso)flavonoids were purified from a licorice root extract and subjected to competition experiments with six commercially available (iso)flavonoids. The agonistic and antagonistic activ... |
|
|
Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.
Br. J. Cancer 100 , 649-655, (2009) Phenoxodiol is a novel isoflav-3-ene, currently undergoing clinical trials, that has a broad in vitro activity against a number of human cancer cell lines. Phenoxodiol alone inhibited DU145 and PC3 in... |
|
|
Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer.
BMC Clin. Pharmacol. 11 , 1, (2011) Phenoxodiol is a novel isoflavone currently being studied in clinical trials for the treatment of cancer. This study reports the pharmacokinetics of phenoxodiol in patients with cancer.The pharmacokin... |
| 2H-1-Benzopyran-7-ol, 3-(4-hydroxyphenyl)- |
| 7-hydroxy-3-(4-hydroxy-phenyl)-2H-1-benzopyran |
| Haginin E |
| 3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol |
| IDRONOXIL |
| Phenoxodiol |
| Dehydroequol |
| 3-(4-Hydroxyphenyl)-2H-chromen-7-ol |
| NV-06 |
| 4',7-dihydroxyisoflav-3-ene |
| 4',7-dihydroxy-3-phenyl-3,4-dehydrochroman |